Page 157 - ASHG 2013 Program Guide

144  
POSTER SESSIONS
W=W
ednesday authors will present; T=Thursday authors will present; F=Friday authors will pr
esent
Complex Traits and Polygenic
Disorders
744
W Fine-mapping classical HLA variation associated
with ankylosing spondylitis susceptibility.
A. Cortes,
S. L. Pulit, P. I. W. de Bakker, M. A. Brown, International
Genetics of Ankylosing Spondylitis Consortium.
745
T Mapping an otitis media gene within an
indigenous population: Evidence for locus
heterogeneity.
E. M. Cutiongco-de la Paz, G. T. Abes, M.
R. T. Reyes-Quintos, C. M. Chiong, M. L. Tantoco, M. C.
Garcia, E. G. Llanes, T. L. Gloria-Cruz, A. L. Chan, J. W.
Belmont, S. M. Leal, R. L. P. Santos-Cortez.
746
F Candidate-gene association study of pain crisis
rate in sickle cell anemia patients.
G. Galarneau, G. Lettre.
747
W Genetic linkage analysis and candidate gene
approach in inbreed Puerto Rican families with
congenital scoliosis.
J. E. Baez, J. C. Orengo, E. Suarez,
C. Burgos, V. Franceschini, A. S. Cornier.
748
T Gene polymorphisms as risk factor for early
primary osteoarthritis of the knee in Asian Indians.
S.
Poornima, K. Subramanyam, Q. Hasan.
749
F Prevalence of specific cell adhesion molecule gen
polymorphisms in recurrent aphthous stomatitis.
A.
Alkhateeb, J. Karasneh, H. Abbadi, A. Hassan, M. Thornhill.
750
W Role of the
DIVERSIN
gene in neural tube
defects in humans.
R. Allache, P. De Marco, E. Merello, V.
Capra, Z. Kibar.
751
T Epistatic interactions between SNPs in
PHF11
and
IFNG
genes increase risk to allergic phenotypes.
A. K.
Andiappan, K. J. Puan, W. S. Yeo, B. T. Lee, R. Melchiotti,
M. Poidinger, D. Y. Wang, O. Rotzschke, F. T. Chew.
752
F Associations of
FOXO3A
and human lifespan in
the Long Life Family Study.
H. T. Bae, A. B. Newman, J.
S. Sanders, T. T. Perls, P. Sebastiani.
753
W Association of endothelial nitric oxide synthase
gene polymorphisms (-786T
.
C, 894G
.
T and 4a/b)
with T2D and its complications (CAD and ESRD).
A. J.
S. Bhanwer, P. Raina, R. Kaur, K. Matharoo.
754
T Contribution of
FTO
(
rs9939609),
PON1
(
rs705379)
and
SLC6A4
(5-
HTTLPR) genes with the genetic
risk for obesity in children from Yucatan, Mexico.
L.
Gonzalez-Herrera, M. J. Lopez-Gonzalez, Z. Carballo-
Cardeña, G. Perez-Mendoza, N. Mendez-Dominguez, D.
Pinto-Escalante.
755
F Polymorphisms in
IL12, NOD1
,
and
TLR
pathway
genes associated with tuberculosis disease and
resistance to
M. tuberculosis
infection.
N. B. Hall, R.
P. Igo, L. L. Malone, F. Qiu, A. Schnell, S. Zalwango, T.
R. Hawn, H. Mayanja-Kizza, W. H. Boom, C. M. Stein,
Tuberculosis Research Unit (TBRU).
731
W Sequence-based characterization of
ADME
variation in two Northeast Asian and 19 1000 Genomes
Project populations.
D. H. Hovelson, Z. Xue, M. Zawistowski,
M. G. Ehm, S. Stocker, A. Gross, I. J. Jang, I. Ieiri, J. E. Lee, L.
R. Cardon, S. L. Chissoe, G. Abecasis, M. R. Nelson.
732
W The
CYP2C19*17
variant is not independently
associated with clopidogrel response.
J. Lewis, S.
Stephens, R. Horenstein, J. O’Connell, K. Ryan, C. Peer, W.
Figg, S. Spencer, M. Pacanowski, B. Mitchell, A. Shuldiner.
733
W A pharmacogenomic approach to targeted
medicine.
A. Albayrak, J. D. Hogan, A. P. Peter, B. R.
Braun, F. D. G. Schacherer.
734
W Exome sequencing of asthmatics with extreme
corticosteroid response.
Q. L. Duan, M. H. Cho, R. Kelly,
W. Qiu, E. R. Mardis, E. R. Bleecker, D. A. Meyers, G. A.
Hawkins, S. P. Peters, J. J. Lima, K. G. Tantisira, S. T. Weiss.
735
W Two-hit models of disease risk in drug-induced
liver injury.
J. I. Goldstein, E. T. Lim, H. Huang, S.
Raychaudhuri, C. Stevens, P. I. W. de Bakker, M. I. Lucena,
A. K. Daly, M. R. Nelson, A. Holden, B. M. Neale, M. J.
Daly, International Severe Adverse Events Consortium.
736
W Pharmacogenomics of glucuronidation in
American Indians: The Strong Heart Family Study.
P. E.
Melton, N. Franceschini, K. Haack, C. Bizon, E. T. Lee, J.
G. Umans, L. G. Best, S. A. Cole, L. A. Almasy.
737
W Primary action of clozapine exposure on
activation of
SREBP
-
controlled lipogenic gene
expression may explain benefit and detriment
J. S. A.
de With, T. Wang, E. Strengman, S. de Jong, W. G. Staal,
R. A. Ophoff.
738
W A phenome-wide association study of ADME core
variants in an EMR-linked biobank.
M. T. Oetjens, J. C.
Denny, N. B. Gillani, M. Herrera, L. Olson, H. H. Dilks, D. M.
Richardson, E. Bowton, D. M. Roden, D. C. Crawford.
739
W Swedegene: Genome-wide association studies
of adverse drug reactions.
M. Wadelius, N. Eriksson, Q.
Ying-Yue, E. Eliasson, H. Melhus, P. Hallberg.
740
W Pharmacogenetics at NCBI.
A. J. Malheiro, W.
Rubinstein, B. Kattman, J. Lee, D. Maglott, V. Hem, M.
Ovetsky, G. Song, K. Katz, C. Wallin, R. Villamarin, J. Ostell.
741
W AlleleTyper Software: A flexible application for
mapping SNP genotype and CNV data patterns to
pharmacogenetic allele nomenclature.
T. Hartshorne, N.
Mehmet, E. Shelton, H. Leong.
742
W Genetic ancestry modifies e fects of naltrexone
on smoking cessation in African Americans: An
analysis of a randomized controlled trial.
A. P. Bress, C.
Wing, A. King, R. Kittles.
743
W Assessment of viability of human lymphocytes
exposed to ionizing radiation and curcumin.
B.
Gonzalez, C. Monterrubio, H. Pimentel, R. Silva, L.
Rodríguez, C. Barba, N. Pérez, B. Inda, J. Vidal, E. Flores,
H. Reyes, L. Bobadilla, A. Corona.